Morita, Akimichi http://orcid.org/0000-0001-8372-3754
Choon, Siew Eng
Bachelez, Hervé
Anadkat, Milan J.
Marrakchi, Slaheddine
Zheng, Min
Tsai, Tsen-Fang
Turki, Hamida
Hua, Harry
Rajeswari, Sushmita
Thoma, Christian
Burden, A. David
Clinical trials referenced in this document:
Documents that mention this clinical trial
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
https://doi.org/10.1136/bmjopen-2020-043666
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
https://doi.org/10.1007/s13555-022-00835-6
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 17 August 2022
Accepted: 11 October 2022
First Online: 5 November 2022
Change Date: 18 December 2022
Change Type: Update
Change Details: Correction to the Data Availability section updated